Cargando…

Surfactant therapy for COVID-19 related ARDS: a retrospective case–control pilot study

BACKGROUND: COVID-19 causes acute respiratory distress syndrome (ARDS) and depletes the lungs of surfactant, leading to prolonged mechanical ventilation and death. The feasibility and safety of surfactant delivery in COVID-19 ARDS patients have not been established. METHODS: We performed retrospecti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Piva, Simone, DiBlasi, Robert M., Slee, April E., Jobe, Alan H., Roccaro, Aldo M., Filippini, Matteo, Latronico, Nicola, Bertoni, Michele, Marshall, John C., Portman, Michael A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7812332/ https://www.ncbi.nlm.nih.gov/pubmed/33461535 http://dx.doi.org/10.1186/s12931-020-01603-w

Ejemplares similares

Efficacy, dose–response, and aerosol delivery of dry powder synthetic lung surfactant treatment in surfactant-deficient rabbits and premature lambs
por: Walther, Frans J., et al.
Publicado: (2022)

Neurological complications of sepsis
por: Piva, Simone, et al.
Publicado: (2023)

Physiologic Effects of Instilled and Aerosolized Surfactant Using a Breath-Synchronized Nebulizer on Surfactant-Deficient Rabbits †
por: DiBlasi, Robert M., et al.
Publicado: (2021)

Breath-Synchronized Nebulized Surfactant in a Porcine Model of Acute Respiratory Distress Syndrome
por: DiBlasi, Robert M., et al.
Publicado: (2021)

Occurrence and Effects on Weaning From Mechanical Ventilation of Intensive Care Unit Acquired and Diaphragm Weakness: A Pilot Study
por: Bertoni, Michele, et al.
Publicado: (2022)

Endotracheal Surfactant Combined With Budesonide for Neonatal ARDS
por: Deliloglu, Burak, et al.
Publicado: (2020)

Reduced levels of pulmonary surfactant in COVID-19 ARDS
por: Schousboe, Peter, et al.
Publicado: (2022)

Surfactant for the Treatment of ARDS in a Patient With COVID-19
por: Heching, Moshe, et al.
Publicado: (2021)

Pulmonary Surfactant in Adult ARDS: Current Perspectives and Future Directions
por: Dushianthan, Ahilanandan, et al.
Publicado: (2023)

Evaluation of a Novel Dry Powder Surfactant Aerosol Delivery System for Use in Premature Infants Supported with Bubble CPAP
por: DiBlasi, Robert M., et al.
Publicado: (2023)

Intensive care unit–acquired weakness: unanswered questions and targets for future research
por: Piva, Simone, et al.
Publicado: (2019)

LUCINACTANT, A SYNTHETIC SURFACTANT FOR TREATMENT OF COVID-19-ASSOCIATED ARDS
por: GUARDIA, CARLOS G, et al.
Publicado: (2022)

The Effect of Exogenous Surfactant on Moderate and Severe Stages of COVID-19 Induced ARDS: the Pilot Study of a Clinical Trial
por: Fani, Kamal, et al.
Publicado: (2021)

The need for clinical ethics consultation: a monocentric observational survey study in the intensive care unit (Consul.E.T.I. study)
por: Filippini, Matteo, et al.
Publicado: (2022)

Critical Illness Weakness, Polyneuropathy and Myopathy: Diagnosis, treatment, and long-term outcomes
por: Latronico, Nicola, et al.
Publicado: (2023)

Publisher Correction to: Critical Illness Weakness, Polyneuropathy and Myopathy: Diagnosis, treatment, and long‑term outcomes
por: Latronico, Nicola, et al.
Publicado: (2023)

The accuracy of transcranial Doppler in excluding intracranial hypertension following acute brain injury: a multicenter prospective pilot study
por: Rasulo, Frank A., et al.
Publicado: (2017)

Excessive Sedation as a Risk Factor for Delirium: A Comparison between Two Cohorts of ARDS Critically Ill Patients with and without COVID-19
por: Rasulo, Frank Anthony, et al.
Publicado: (2022)

Comparison between a nurse-led weaning protocol and weaning based on physician’s clinical judgment in tracheostomized critically ill patients: a pilot randomized controlled clinical trial
por: Fagoni, Nazzareno, et al.
Publicado: (2018)

A pilot study to assess short-term physiologic outcomes of transitioning infants with severe bronchopulmonary dysplasia from ICU to two subacute ventilators
por: DiBlasi, Robert M., et al.
Publicado: (2018)

Lipid profile modifications of the lung tissue and surfactant in a murine model of malaria associated ARDS
por: Scaccabarozzi, Diletta, et al.
Publicado: (2012)

Co-aerosolized Pulmonary Surfactant and Ambroxol for COVID-19 ARDS Intervention: What Are We Waiting for?
por: Kumar, Pradeep
Publicado: (2020)

Surfactant therapies for pediatric and neonatal ARDS: ESPNIC expert consensus opinion for future research steps
por: De Luca, Daniele, et al.
Publicado: (2021)

A New Method for In Vivo Analysis of the Performances of a Heat and Moisture Exchanger (HME) in Mechanically Ventilated Patients
por: Filippini, Matteo, et al.
Publicado: (2019)

Surfactant replacement and open lung concept – Comparison of two treatment strategies in an experimental model of neonatal ARDS
por: Hilgendorff, Anne, et al.
Publicado: (2008)

Alveolar Tissue Fiber and Surfactant Effects on Lung Mechanics—Model Development and Validation on ARDS and IPF Patients
Publicado: (2021)

The Association Between Peri-Hemorrhagic Metabolites and Cerebral Hemodynamics in Comatose Patients With Spontaneous Intracerebral Hemorrhage: An International Multicenter Pilot Study Analysis
por: Rasulo, Frank, et al.
Publicado: (2020)

Drug Reaction with Eosinophilia and Systemic Symptoms: DRESS following Initiation of Oxcarbazepine with Elevated Human Herpesvirus-6 Titer
por: Cornell, Seth L., et al.
Publicado: (2014)

Genetic contributions to suicidal thoughts and behaviors
por: DiBlasi, Emily, et al.
Publicado: (2021)

Seeking the Light in Intensive Care Unit Sedation: The Optimal Sedation Strategy for Critically Ill Patients
por: Gitti, Nicola, et al.
Publicado: (2022)

Exogenous pulmonary surfactant in COVID-19 ARDS. The similarities to neonatal RDS suggest a new scenario for an ‘old’ strategy
por: Bhatt, Reena M, et al.
Publicado: (2021)

Metabolic Syndrome in Adults With Congenital Heart Disease
por: Deen, Jason F., et al.
Publicado: (2016)

Clinical presentation and initial management critically ill patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in Brescia, Italy
por: Piva, Simone, et al.
Publicado: (2020)

Sustained Inflation at Birth Did Not Alter Lung Injury from Mechanical Ventilation in Surfactant-Treated Fetal Lambs
por: Hillman, Noah H., et al.
Publicado: (2014)

Veno-venous ECMO as a platform to evaluate lung lavage and surfactant replacement therapy in an animal model of severe ARDS
por: Qaqish, Robert, et al.
Publicado: (2020)

Correlation of Surfactant Protein-D (SP-D) Serum Levels with ARDS Severity and Mortality in Covid-19 Patients in Indonesia
por: Agustama, Alexander, et al.
Publicado: (2022)

Surfactant Self-Assembling and Critical Micelle Concentration: One Approach Fits All?
por: Perinelli, Diego Romano, et al.
Publicado: (2020)

Late administration of surfactant replacement therapy increases surfactant protein-B content: a randomized pilot study
por: Keller, Roberta L., et al.
Publicado: (2012)

Spatial and Temporal Complexities of Reproductive Behavior and Sex Ratios: A Case from Parasitic Insects
por: Dittmar, Katharina, et al.
Publicado: (2011)

Severe COVID-19 ARDS Treated by Bronchoalveolar Lavage with Diluted Exogenous Pulmonary Surfactant as Salvage Therapy: In Pursuit of the Holy Grail?
por: Ruaro, Barbara, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7ji7d4cpkomdp4dngmrn3mcpms